mortality/aging
• mutants do not survive for more than 10 months and most often die around 8 months of age
|
neoplasm
• all mice develop hepatocellular carcinoma at 8 months of age
• tumor development begins with the appearance of small, numerous and well-delimited tumoral nodules by 4 months of age, development into hepatocellular adenomas at 6 months of age, and finally complete disorganization of the hepatic architecture with numerous foci of polyadenoid, glanduliform and trabecular hepatocarcinoma
|
• lung metastasis is observed in some mutants
|
liver/biliary system
• mutants exhibit anisocaryosis and abnormal mitosis in the liver at 2 months of age
|
• all mice develop hepatocellular carcinoma at 8 months of age
• tumor development begins with the appearance of small, numerous and well-delimited tumoral nodules by 4 months of age, development into hepatocellular adenomas at 6 months of age, and finally complete disorganization of the hepatic architecture with numerous foci of polyadenoid, glanduliform and trabecular hepatocarcinoma
|
• hepatic cytolysis occurs as early as 3-4 weeks of age and reaches a first peak at 7 weeks, before the formation of nodules, then a second increase in cytolysis is seen between 6-8 months
|
cellular
• anisocaryosis in the liver at 2 months of age
|
hematopoietic system
anisocytosis
(
J:101541
)
• seen at 2 months of age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hepatocellular carcinoma | DOID:684 |
OMIM:114550 |
J:101541 |